MICHELLE ROSS: Open Payments
NPI 1871612895 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 10 payments from 6 companies in 2025. Trend: 2023 $209 · 2024 $237 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $148 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: LEQVIO, ENTRESTO, FUROSCIX, ELIQUIS, ONYX FRONTIER.
Industry payments across NC — which companies pay providers there.
